EA201792319A1 - Полиморфы триазолонового соединения, ингибирующего pges-1 - Google Patents
Полиморфы триазолонового соединения, ингибирующего pges-1Info
- Publication number
- EA201792319A1 EA201792319A1 EA201792319A EA201792319A EA201792319A1 EA 201792319 A1 EA201792319 A1 EA 201792319A1 EA 201792319 A EA201792319 A EA 201792319A EA 201792319 A EA201792319 A EA 201792319A EA 201792319 A1 EA201792319 A1 EA 201792319A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- inhibiting
- polymorphes
- pges
- triazolone compound
- triazolone
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title abstract 3
- -1 TRIAZOLONE COMPOUND Chemical class 0.000 title abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 101710096361 Prostaglandin E synthase Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- DOVBVLUPCQSAGE-UHFFFAOYSA-N n-[[4-chloro-3-[3-oxo-2-[4-(trifluoromethyl)phenyl]-1h-1,2,4-triazol-5-yl]phenyl]methyl]-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NCC1=CC=C(Cl)C(C=2NN(C(=O)N=2)C=2C=CC(=CC=2)C(F)(F)F)=C1 DOVBVLUPCQSAGE-UHFFFAOYSA-N 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N2021/3595—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using FTIR
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
- G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
- G01N23/20075—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials by measuring interferences of X-rays, e.g. Borrmann effect
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящая заявка относится к твердым формам триазолонового соединения, которое демонстрирует ингибирующую активность в отношении фермента mPGES-1, a именно N-(4-хлор-3-(5-оксо-1-(4-(трифторметил)фенил)-4,5-дигидро-1H-1,2,4-триазол-3-ил)бензил)пиваламида (соединения формулы II), и к способам их получения.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2275MU2015 | 2015-06-12 | ||
PCT/IB2016/053467 WO2016199104A1 (en) | 2015-06-12 | 2016-06-13 | Polymorphs of a pges-1 inhibiting triazolone compound |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201792319A1 true EA201792319A1 (ru) | 2018-05-31 |
EA034646B1 EA034646B1 (ru) | 2020-03-02 |
Family
ID=56615983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201792319A EA034646B1 (ru) | 2015-06-12 | 2016-06-13 | Кристаллическая форма n-(4-хлор-3-(5-оксо-1-(4-(трифторметил)фенил)-4,5-дигидро-1h-1,2,4-триазол-3-ил)бензил)пиваламида и способ её получения |
Country Status (11)
Country | Link |
---|---|
US (2) | US10112914B2 (ru) |
EP (1) | EP3307718B1 (ru) |
JP (1) | JP2018517723A (ru) |
CN (1) | CN107820489A (ru) |
AU (1) | AU2016275360B2 (ru) |
BR (1) | BR112017026286A2 (ru) |
CA (1) | CA2987031A1 (ru) |
EA (1) | EA034646B1 (ru) |
MX (1) | MX2017016042A (ru) |
WO (1) | WO2016199104A1 (ru) |
ZA (1) | ZA201707682B (ru) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR084174A1 (es) * | 2010-12-21 | 2013-04-24 | Lilly Co Eli | Compuestos de imidazol-2-benzamida utiles para el tratamiento de osteoartritis y una composicion farmaceutica |
TWI568722B (zh) * | 2012-06-15 | 2017-02-01 | 葛蘭馬克製藥公司 | 作爲mPGES-1抑制劑之三唑酮化合物 |
CN104211704B (zh) * | 2013-06-03 | 2017-08-25 | 杭州领业医药科技有限公司 | 结晶形态的三唑[4,5‑d]嘧啶化合物及其制备方法和用途 |
-
2016
- 2016-06-13 AU AU2016275360A patent/AU2016275360B2/en not_active Ceased
- 2016-06-13 US US15/573,387 patent/US10112914B2/en not_active Expired - Fee Related
- 2016-06-13 JP JP2017564615A patent/JP2018517723A/ja active Pending
- 2016-06-13 CA CA2987031A patent/CA2987031A1/en not_active Abandoned
- 2016-06-13 WO PCT/IB2016/053467 patent/WO2016199104A1/en active Application Filing
- 2016-06-13 CN CN201680033550.0A patent/CN107820489A/zh active Pending
- 2016-06-13 EA EA201792319A patent/EA034646B1/ru not_active IP Right Cessation
- 2016-06-13 BR BR112017026286A patent/BR112017026286A2/pt not_active Application Discontinuation
- 2016-06-13 EP EP16748346.0A patent/EP3307718B1/en active Active
- 2016-06-13 MX MX2017016042A patent/MX2017016042A/es unknown
-
2017
- 2017-11-13 ZA ZA2017/07682A patent/ZA201707682B/en unknown
-
2018
- 2018-08-31 US US16/119,306 patent/US10457649B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US10112914B2 (en) | 2018-10-30 |
US20180370923A1 (en) | 2018-12-27 |
MX2017016042A (es) | 2018-02-21 |
BR112017026286A2 (pt) | 2018-09-11 |
WO2016199104A1 (en) | 2016-12-15 |
AU2016275360A1 (en) | 2017-12-07 |
AU2016275360B2 (en) | 2020-02-06 |
EP3307718B1 (en) | 2020-12-30 |
CA2987031A1 (en) | 2016-12-15 |
US10457649B2 (en) | 2019-10-29 |
JP2018517723A (ja) | 2018-07-05 |
US20180134671A1 (en) | 2018-05-17 |
EP3307718A1 (en) | 2018-04-18 |
EA034646B1 (ru) | 2020-03-02 |
CN107820489A (zh) | 2018-03-20 |
ZA201707682B (en) | 2019-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202091893A1 (ru) | Новые кристаллические формы | |
DK3606909T3 (da) | Natriumsalt af n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1h-pyrazol-3-sulfonamid | |
DK3755703T3 (da) | N-(phenyl)-2-(phenyl)pyrimidin-4-carboxamidderivater og relaterede forbindelser som hpk1-inhibitorer til behandling af kræft | |
EA201691701A1 (ru) | Применение 3-изоксазолидиноновых соединений в качестве селективных гербицидов | |
EA201891024A1 (ru) | Соединения-ингибиторы tank-связывающей киназы | |
EA201692446A1 (ru) | Инсектицидная, майтицидная, нематоцидная, моллюскоцидная, микробицидная или бактерицидная композиция и способ борьбы с вредителями | |
EA201001359A1 (ru) | Гетероциклические соединения в качестве ингибиторов cxcr2 | |
EA201190144A1 (ru) | Изотиазолилоксифениламидины и их применение в качестве фунгицидов | |
UA122520C2 (uk) | Кристалічна форма 2-[4-(4-хлорфенокси)-2-(трифторметил)феніл]-1-(1,2,4-триазол-1-іл)пропан-2-олу, агрохімічна композиція, застосування та спосіб боротьби зі шкідливими грибами | |
UA110657C2 (uk) | Сільськогосподарська і садова фунгіцидна композиція | |
EA201100094A1 (ru) | Тиадиазолилоксифениламидины и их применение в качестве фунгицидов | |
EA201990279A1 (ru) | Гербицидные композиции, содержащие фенилпиримидины | |
EA201100093A1 (ru) | Тиадиазолилоксифениламидины и применение их в качестве фунгицидов | |
EA201590330A1 (ru) | Соли и твердые формы (s)-3-(4-((4-(морфолинометил)бензил)окси)-1-оксоизоиндолин-2-ил)пиперидин-2,6-диона и включающие их композиции и способы их применения | |
ATE490962T1 (de) | Co-kristalle von propiconazol | |
MX2011013287A (es) | Combinaciones herbicidas basadas en carbamoil triazolinone y procesos de uso. | |
EA201692474A1 (ru) | Производные 1-(циклопент-2-ен-1-ил)-3-(2-гидрокси-3-(арилсульфонил)фенил)мочевины в качестве ингибиторов cxcr2 | |
EA201991428A1 (ru) | Фармацевтическая комбинация, содержащая блокатор кальциевых каналов т-типа | |
EA202090933A1 (ru) | Способ получения гербицидных соединений пиридазинона | |
EA201891430A1 (ru) | Твердые формы замещенных 5,6-дигидро-6-фенилбензо[f]изохинолин-2-аминовых соединений | |
EA201792558A1 (ru) | Противогрибковый 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-триазол-1-ил)метил)-5-(2,4-дифторфенил)тетрагидрофуран-3-ил)метокси)-3-метилфенил)пиперазин-1-ил)-n-(2-гидроксициклогексил)бензамид или его фармацевтически приемлемая соль | |
EA201891240A1 (ru) | 1,3,4-тиадиазольные соединения и их применение в лечении рака | |
EA201792319A1 (ru) | Полиморфы триазолонового соединения, ингибирующего pges-1 | |
EA201992360A1 (ru) | Кристаллические формы (s)-афоксоланера | |
PH12017500123A1 (en) | Crystal of azole benzene derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |